Research progress on berberine with a special focus on its oral bioavailability
Abstract
The natural product berberine (BBR) has become a potential drug in the treatment of diabetes, hyperlipidemia, and cancer. However, the oral delivery of BBR is challenged by its poor bioavailability. It is necessary to improve the oral bioavailability of BBR before it can be used in many clinical applications. Understanding the pharmacokinetic characteristics of BBR will enable the development of suitable formulas that have improved oral bioavailability. The key considerations for BBR are how to enhance the drug absorption and to avoid the intestinal first-pass effect. This review summarizes the pharmacological activities of BBR and analyzes the factors that lead to its poor oral bioavailability. In particular, the therapeutic potential of BBR in new indications from the aspect of oral bioavailability is discussed. In conclusion, BBR is a promising drug candidate for metabolic disorders and cancer but faces considerable challenges due to its poor oral bioavailability.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Absolute oral bioavailability of berberine is below 1% in rats and below a few percent in humans.
“The absolute oral bioavailability of berberine is very low, estimated to be below 1% in rats and below a few percent in humans [48,49,50]”
From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [50]
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394 · see citing works
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · see citing works
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550 · see citing works
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391 · see citing works
Drug Metabolism and Variability among Patients in Drug Response
Wilkinson, G. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra032424 · Cited by 1,185 · see citing works
Rendić, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 1,165 · see citing works
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967 · see citing works
Efficacy of berberine in patients with type 2 diabetes mellitus
Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801 · see citing works
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 766 · see citing works
Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630 · see citing works
Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042529 · Cited by 615 · see citing works
Self-citationEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 510 · see citing works
Zhang, J., Guo, Z., Xue, Z., Sun, Z., Zhang, M., Wang, L., Wang, G., Wang, F., Xu, J., Cao, H., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2015.11 · Cited by 458 · see citing works
Self-citationZhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z., Wang, S., Zhou, Z.-X., Song, D., Wang, Y., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.029 · Cited by 442 · see citing works
Berberine activates thermogenesis in white and brown adipose tissue
Zhang, Z., Zhang, H., Li, B., Meng, X.-J., Wang, J., Zhang, Y., Yao, S., Ma, Q., Jin, L., Yang, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6493 · Cited by 439 · see citing works
Self-citationComparison Between Permeability Coefficients in Rat and Human Jejunum
Fagerholm, U., Johansson, M., & Lennernäs, H. (1996) · Pharmaceutical Research · doi:10.1023/a:1016065715308 · Cited by 438 · see citing works
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 427 · see citing works
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. K. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 412 · see citing works
Berberine improves glucose metabolism through induction of glycolysis
Yin, J., Gao, Z., Liu, D., Liu, Z., & Ye, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00211.2007 · Cited by 411 · see citing works
Herbal Modulation of P‐Glycoprotein
Zhou, S., Lim, L. Y., & Chowbay, B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120028427 · Cited by 375 · see citing works
Chen, W., Miao, Y.-Q., Fan, D.-J., Yang, S.-S., Lin, X., Meng, L.-K., & Tang, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9632-z · Cited by 363 · see citing works
Liu, Y.-T., Hao, H.-P., Xie, H.-G., Lai, L., Wang, Q., Liu, C.-X., & Wang, G.-J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033936 · Cited by 356 · see citing works
Self-citationLi, H., Dong, B., Park, S. W., Lee, H.-S., Chen, W., & Liu, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052407 · Cited by 349 · see citing works
Transforming berberine into its intestine-absorbable form by the gut microbiota
Feng, R., Shou, J.-W., Zhao, Z.-X., He, C.-Y., Ma, C., Huang, M., Fu, J., Tan, X.-S., Li, X.-Y., Wen, B.-Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12155 · Cited by 307 · see citing works
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J. F., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307 · see citing works
Application of Chitin and Chitosan Derivatives in the Pharmaceutical Field
Katō, Y., Onishi, H., & Machida, Y. (2003) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201033489748 · Cited by 301 · see citing works
Zuo, F., Nakamura, N., Akao, T., & Hattori, M. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011361 · Cited by 284 · see citing works
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278 · see citing works
Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats
Tan, X.-S., Ma, J.-Y., Feng, R., Ma, C., Chen, W.-J., Sun, Y.-P., Fu, J., Huang, M., He, C.-Y., Shou, J.-W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077969 · Cited by 266 · see citing works
Kong, W., Zhang, H., Song, D., Xue, R., Zhao, W., Wei, J., Wang, Y., Shan, N., Zhou, Z., Yang, P., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.013 · Cited by 266 · see citing works
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze‐Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265 · see citing works
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
Xia, X., Yan, J., Shen, Y., Tang, K., Yin, J., Zhang, Y., Yang, D., Liang, H., Ye, J., & Weng, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016556 · Cited by 262 · see citing works
Self-citationBattu, S. K., Repka, M. A., Maddineni, S., Chittiboyina, A. G., Avery, M. A., & Majumdar, S. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9520-y · Cited by 261 · see citing works
Berberine decreases PCSK9 expression in HepG2 cells
Cameron, J., Ranheim, T., Kulseth, M. A., Leren, T. P., & Berge, K. E. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.004 · Cited by 232 · see citing works
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Maher, S., Leonard, T. W., Jacobsen, J. B., & Brayden, D. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.006 · Cited by 227 · see citing works
Yu, L. X., Bridgers, A., Polli, J. W., Vickers, A. W., Long, S. T., Roy, A., Winnike, R., & Coffin, M. D. (1999) · Pharmaceutical Research · doi:10.1023/a:1018939006780 · Cited by 225 · see citing works
The involvement of P-glycoprotein in berberine absorption
Pan, G., Wang, G., Liu, X., Fawcett, J. P., & Xie, Y. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.t01-1-910403.x · Cited by 225 · see citing works
Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysis
Dong, H., Wang, N., Zhao, L., & Lu, F. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/591654 · Cited by 225 · see citing works
Anderberg, E. K., Lindmark, T., & Artursson, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018909210879 · Cited by 221 · see citing works
Rabbani, G. H., Butler, T., Knight, J., Sanyal, S. C., & Alam, K. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.5.979 · Cited by 215 · see citing works
Coadministration of Cyclosporine Strongly Enhances the Oral Bioavailability of Docetaxel
Malingré, M. M., Richel, D. J., Beijnen, J. H., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1160 · Cited by 199 · see citing works
Hua, W., Ding, L., Chen, Y., Gong, B., He, J., & Xu, G. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.03.022 · Cited by 192 · see citing works
The biology of Gram-positive sortase enzymes
Paterson, G. K., & Mitchell, T. J. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2003.12.007 · Cited by 185 · see citing works
Bogman, K., Erne-Brand, F., Alsenz, J., & Drewe, J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10395 · Cited by 184 · see citing works
Abbud, W., Habinowski, S. A., Zhang, J.-Z., Kendrew, J., Elkairi, F. S., Kemp, B. E., Witters, L. A., & Ismail‐Beigi, F. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1935 · Cited by 184 · see citing works
Xie, W., Gu, D., Li, J., Cui, K., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024520 · Cited by 183 · see citing works
Self-citationAbidi, P., Zhou, Y., Jiang, J., & Liu, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 176 · see citing works
Antimicrobial activity of berberine—a constituent ofMahonia aquifolium
Čerňáková, M., & Košťálová, D. (2002) · Folia Microbiologica · doi:10.1007/bf02818693 · Cited by 174 · see citing works
Cano-Cebrián, M. J., Zornoza, T., Granero, L. M., et al. (2005) · Current Drug Delivery · doi:10.2174/1567201052772834 · Cited by 171 · see citing works
Spinozzi, S., Colliva, C., Camborata, C., Roberti, M., Ianni, C., Neri, F., Calvarese, C., Lisotti, A., Mazzella, G., & Roda, A. (2014) · Journal of Natural Products · doi:10.1021/np400607k · Cited by 161 · see citing works
HEPATOBILIARY EXCRETION OF BERBERINE
Tsai, P.-L., & Tsai, T. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.405 · Cited by 160 · see citing works
Bansal, T., Akhtar, N., Jaggi, M., Khar, R. K., & Talegaonkar, S. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.010 · Cited by 157 · see citing works
Xue, M., Yang, M.-X., Zhang, W., Li, X.-M., Gao, D., Ou, Z., Li, Z., Li, X., Liu, S.-H., & Yang, S. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51262 · Cited by 154 · see citing works
Ho, Y.-T., Yang, J., Li, T., Lin, J., Lin, J., Lai, K., Ma, C.-Y., Wood, W. G., & Chung, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.033 · Cited by 150 · see citing works
Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance
Fu, L., Liang, Y.-J., Deng, L., Ding, Y. P., Chen, L., Ye, Y.-L., Yang, X., & Pan, Q. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0742-5 · Cited by 145 · see citing works
Bansal, T., Mishra, G., Jaggi, M., Khar, R. K., & Talegaonkar, S. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.12.005 · Cited by 140 · see citing works
Berberine Activates GLUT1-Mediated Glucose Uptake in 3T3-L1 Adipocytes
Kim, S. H., Shin, E.-J., Kim, E.-D., Bayaraa, T., Frost, S. C., & Hyun, C. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2120 · Cited by 136 · see citing works
Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla
Freile, M. L., Giannini, F., Pucci, G. N., et al. (2003) · Fitoterapia · doi:10.1016/s0367-326x(03)00156-4 · Cited by 136 · see citing works
Bardelmeijer, H. A., Ouwehand, M., Buckle, T., et al. (2002) · PubMed · Cited by 135 · see citing works
Zhang, Z., Chen, Y., Deng, J. G., Jia, X., Zhou, J., & Lv, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.01.023 · Cited by 135 · see citing works
Cardiovascular effects of berberine in patients with severe congestive heart failure
Marin ‐ NETO, J. A., Maciel, B. C., Secches, A. L., & Gallo, L. (1988) · Clinical Cardiology · doi:10.1002/clc.4960110411 · Cited by 128 · see citing works
Chen, C., Tao, C., Liu, Z., Lü, M., Pan, Q., Zheng, L., Li, Q., Song, Z., & Fichna, J. (2015) · Phytotherapy Research · doi:10.1002/ptr.5475 · Cited by 127 · see citing works
Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
Zhang, Q., Xiao, X., Feng, K., Wang, T., Li, W., Yuan, T., Sun, X., Sun, Q., Xiang, H., & Wang, H. (2010) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/924851 · Cited by 124 · see citing works
Wang, L., Liu, L., Shi, Y., Cao, H., Chaturvedi, R., Calcutt, M. W., Hu, T., Ren, X., Wilson, K. T., Polk, D. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036418 · Cited by 123 · see citing works
The effects of pharmaceutical excipients on drug disposition
Buggins, T. R., Dickinson, P. A., & Taylor, G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.017 · Cited by 122 · see citing works
Zhu, J.-X., Tang, D., Feng, L., Zheng, Z., Wang, R.-S., Wu, A., Duan, T., He, B., & Quan, Z. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.683875 · Cited by 113 · see citing works
Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes
Liu, B., Wang, G., Yang, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021416 · Cited by 113 · see citing works
Wang, Y., Yi, X., Ghanam, K., Zhang, S., Zhao, T.-T., & Zhu, X. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.013 · Cited by 112 · see citing works
Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes
Li, Y., Ren, G., Wang, Y.-X., Kong, W.-J., Yang, P., Wang, Y.-M., Li, Y.-H., Yi, H., Li, Z.-R., Song, D.-Q., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-62 · Cited by 109 · see citing works
Zhang, X., Qiu, F., Jiang, J. C., Gao, C., & Tan, Y. (2011) · Xenobiotica · doi:10.3109/00498254.2010.529180 · Cited by 109 · see citing works
Excretion of Berberine and Its Metabolites in Oral Administration in Rats
Ma, J., Feng, R., Tan, X., Ma, C., Shou, J., Fu, J., Huang, M., He, C., Chen, S., Zhao, Z., et al. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23718 · Cited by 107 · see citing works
Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor
Chu, M., Ding, R., Chu, Z.-Y., Zhang, M., Liu, X.-Y., Xie, S.-H., Zhai, Y.-J., & Wang, Y. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-89 · Cited by 106 · see citing works
Jiang, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7777 · Cited by 104 · see citing works
Binding Thermodynamics of Statins to HMG-CoA Reductase
Carbonell, T., & Freire, E. (2005) · Biochemistry · doi:10.1021/bi050905v · Cited by 102 · see citing works
Liu, Y., Hao, H., Xie, H., Lv, H., Liu, C., & Wang, G. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21721 · Cited by 101 · see citing works
Self-citationChemical Stability of Nucleic Acid–Derived Drugs
Pogocki, D., & Schöneich, C. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4 · Cited by 100 · see citing works
Li, Y., Yang, P., Kong, W., Wang, Y., Hu, C.-Q., Zuo, Z.-Y., Wang, Y., Gao, H., Gao, L., Feng, Y., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801157z · Cited by 96 · see citing works
Wang, T., Wang, N., Song, H., Xi, X., Wang, J., Hao, A., & Li, T. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.06.015 · Cited by 96 · see citing works
Kim, S.-H., Shin, D., Oh, M., Chung, S., Jang-Suk, L. E. E., & Oh, K. (2004) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.68.421 · Cited by 95 · see citing works
Determination of berberine in plasma, urine and bile by high-performance liquid chromatography
Chen, C., & Chang, H.-C. (1995) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(94)00517-9 · Cited by 92 · see citing works
Li, H., Chen, W., Zhou, Y., Abidi, P., Sharpe, O., Robinson, W. H., Kraemer, F. B., & Liu, J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800375-jlr200 · Cited by 92 · see citing works
Li, N., Gu, L., Qu, L., Gong, J., Li, Q., Zhu, W., & Li, J. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.02.001 · Cited by 89 · see citing works
Pierro, F. D., Villanova, Agostini, F., Soverini, V., Marchesini, G., & Marzocchi (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s33718 · Cited by 87 · see citing works
Meng, Z., Zhang, M., Shengnan, W., Xiaojia, B., Hatch, G. M., Gu, J., & Li, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.017 · Cited by 86 · see citing works
CYP2D plays a major role in berberine metabolism in liver of mice and humans
Guo, Y., Li, F., Ma, X., Cheng, X., Zhou, H., & Klaassen, C. D. (2011) · Xenobiotica · doi:10.3109/00498254.2011.597456 · Cited by 86 · see citing works
Zhang, M., Lv, X., Li, J., Meng, Z., Wang, Q., Chang, W., Li, W., Chen, L., & Liu, Y. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.006 · Cited by 84 · see citing works
Li, X., Zhao, Z., Huang, M., Feng, R., He, C., Ma, C., Luo, S.-H., Fu, J., Wen, B., Ren, L., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0629-3 · Cited by 81 · see citing works
Xie, Q., Johnson, B. R., Wenckus, C. S., et al. (2012) · Journal of Endodontics · doi:10.1016/j.joen.2012.04.023 · Cited by 80 · see citing works
Pierro, F. D., Putignano, P., Montesi, L., Moscatiello, S., Marchesini, G., & Villanova, N. (2013) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s54308 · Cited by 78 · see citing works
Alkaloids from Corydalis saxicola and Their Anti‐Hepatitis B Virus Activity
Li, H., Han, T., Liu, R., et al. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890074 · Cited by 75 · see citing works
Berberine acutely activates the glucose transport activity of GLUT1
Cok, A., Rosenberger, C. L., Salie, M. J., Oram, D. S., Chenge, J., & Louters, L. L. (2011) · Biochimie · doi:10.1016/j.biochi.2011.04.013 · Cited by 73 · see citing works
Zhang, H., Yang, J., Zhou, F., et al. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/965016 · Cited by 66 · see citing works
A Receptor‐Mediated Pathway for Cholesterol Homeostasis (Nobel Lecture)
Brown, M. S., & Goldstein, J. L. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198605833 · Cited by 65 · see citing works
Karaosmanoğlu, K., Sayar, N. A., Kurnaz, I. A., & Akbulut, B. S. (2013) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2013.0100 · Cited by 64 · see citing works
Yang, P., Song, D., Li, Y., Kong, W., Wang, Y., Gao, L., Liu, S., Cao, R., & Jiang, J. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.005 · Cited by 64 · see citing works
Derosa, G., Bonaventura, A., Bianchi, L., Romano, D., D’Angelo, A., Fogari, E., & Maffioli, P. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.832751 · Cited by 64 · see citing works
Jiang, X., Zhang, Y., Zhu, Y., et al. (2012) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2012.09.009 · Cited by 61 · see citing works
Self-citationBandyopadhyay, S., Bandyopadhyay, S., Patra, P. H., et al. (2013) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(13)60063-2 · Cited by 61 · see citing works
How important is intestinal cytochrome P450 3A metabolism?
van Herwaarden, A. E., van Waterschoot, R. A. B., & Schinkel, A. H. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.003 · Cited by 54 · see citing works
Kosalec, I., Gregurek, B., Kremer, D., et al. (2008) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-008-9860-x · Cited by 53 · see citing works
Enhancement of Sodium Caprate on Intestine Absorption and Antidiabetic Action of Berberine
Lv, X., Li, J., Zhang, M., Wang, C., Fan, Z., Wang, C., & Chen, L. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9386-z · Cited by 53 · see citing works
Shan, Y., Ren, G., Wang, Y., Pang, J., Zhao, Z., Yao, J., You, X., Si, S., Song, D., Kong, W., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.009 · Cited by 53 · see citing works
Tetrandrine Potentiates the Hypoglycemic Efficacy of Berberine by Inhibiting P-Glycoprotein Function
Shan, Y., Zhu, Y., Pang, J., Wang, Y., Song, D., Kong, W., & Jiang, J. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00272 · Cited by 52 · see citing works
Chen, W., Fan, D., Meng, L., Miao, Y., Yang, S., Weng, Y., He, H., & Tang, X. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.592531 · Cited by 52 · see citing works
Chang, X., Yan, H., Xu, Q., Xia, M., Bian, H., Zhu, T., & Gao, X. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-86 · Cited by 52 · see citing works
Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters
Wang, Y., Jia, X., Ghanam, K., Beaurepaire, C., Zidichouski, J. A., & Miller, L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.050 · Cited by 51 · see citing works
Xie, X., Li, W., Lan, T., Liu, W., Peng, J., Huang, K., Huang, J., Shen, X., Liu, P., & Huang, H. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-024 · Cited by 51 · see citing works
He, W., Wang, B., Zhuang, Y., Shao, D., Sun, K., & Chen, J. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12052fp · Cited by 49 · see citing works
Di Pierro, F., Bellone, I., Rapacioli, G., & Putignano, P. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s78877 · Cited by 48 · see citing works
Wu, S., & Hopkins, W. (1999) · Pharmaceutical technology · Cited by 47 · see citing works
Fan, D., Wu, X., Dong, W., Sun, W., Li, J., & Tang, X. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.723219 · Cited by 46 · see citing works
Shen, N., Yi, H., & Shen, Z. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.052 · Cited by 46 · see citing works
Malingré, M. M., Beijnen, J. H., Rosing, H., et al. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000226 · Cited by 43 · see citing works
Liu, Z., Hirano, T., Tanaka, S., Onda, K., & Oka, K. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022115 · Cited by 43 · see citing works
Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine
Swabb, E. A., Tai, Y. H., & Jordan, L. W. (1981) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1981.241.3.g248 · Cited by 42 · see citing works
Alani, A. W. G., Rao, D. A., Seidel, R., Wang, J., Jiao, J., & Kwon, G. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22111 · Cited by 41 · see citing works
Berberine inhibits the proliferation of human uterine leiomyoma cells
Wu, H.-L., Chuang, T.-Y., Al-Hendy, A. A., Diamond, M. P., Azziz, R., & Chen, Y.-H. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.01.010 · Cited by 38 · see citing works
Derosa, G., Bonaventura, A., Bianchi, L., Romano, D., Angelo, A. D., Fogari, E., & Maffioli, P. (2013) · PubMed · Cited by 35 · see citing works
Gong, Z., Chen, Y., Zhang, R., Wang, Y., Guo, Y. H., Yang, Q., Zhang, H., Dong, Y. J., Weng, X., Gao, S., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010456 · Cited by 30 · see citing works
Refaat, A., Abdelhamed, S., Saiki, I., et al. (2015) · Oncology Letters · doi:10.3892/ol.2015.3494 · Cited by 29 · see citing works
Tan, B., Ma, Y., Shi, R., et al. (2007) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.578 · Cited by 29 · see citing works
Effect of berberine on myoelectric activity and transit of the small intestine in rats
Eaker, E. Y., & Sninsky, C. A. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90519-2 · Cited by 28 · see citing works
Stability of the i.v. and oral formulations of etoposide in solution
Joel, S. P., CLARK, P. I., & Slevin, M. L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685638 · Cited by 25 · see citing works
[Effect of berberine on transit time of human small intestine].
Yuan, J., Shen, X. Z., & Zhu, X. (1994) · PubMed · Cited by 19 · see citing works
Assessment of the anti-diarrhea function of compound Chinese herbal medicine cangpo oral liquid
Xia, X., Wang, H., Niu, X., et al. (2013) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v11i1.22 · Cited by 18 · see citing works
Radioiodination, biodistribution and pharmacokinetics of berberine in mice
Li, Z., Wei, Y., & Chu, T. (2005) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-005-0832-4 · Cited by 13 · see citing works
[Effectiveness of berberine in bacillary dysentery].
CHANG, Y. (1959) · PubMed · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Madeo, F., Carmona-Gutierrez, D., Hofer, S. J., & Kroemer, G. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.018 · Cited by 630 · see citing works
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465 · see citing works
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281 · see citing works
Li, C., Ai, G., Wang, Y., Lu, Q., Luo, C., Tan, L., Lin, G., Liu, Y., Li, Y., Zeng, H., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104603 · Cited by 262 · see citing works
Sut, S., Faggian, M., Baldan, V., Poloniato, G., Castagliuolo, I., Grabnar, I., Perissutti, B., Brun, P., Maggi, F., Voinovich, D., et al. (2017) · Molecules · doi:10.3390/molecules22111921 · Cited by 120 · see citing works
Cicero, A. F. G., Fogacci, F., Stoian, A. P., Vrablik, M., Al Rasadi, K., Banach, M., Toth, P. P., & Rizzo, M. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00955-y · Cited by 110 · see citing works
Kwon, M., Lim, D. Y., Lee, C. H., Jeon, J.-H., Choi, M.-K., & Song, I.-S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090882 · Cited by 76 · see citing works
“About 56% of the berberine oral dose was not absorbed because of the P-gp-mediated efflux and self-aggregation of berberine [12].”
BackgroundInfluentialThe mechanism of berberine alleviating metabolic disorder based on gut microbiome
Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69 · see citing works
“The extremely low plasma concentrations following oral administration of BBR in experimental or clinical settings are not sufficient to achieve the effects observed in in vitro experiments, which presents challenges in explaining its excellent and diverse pharmacological effects in clinical trials (Tan et al., 2013; L…”
BackgroundFogacci, F., Grassi, D., Rizzo, M., & Cicero, A. F. G. (2019) · Phytotherapy Research · doi:10.1002/ptr.6282 · Cited by 61 · see citing works
Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
Han, Y., Xiang, Y., Shi, Y., Tang, X., Pan, L., Gao, J., Bi, R., & Lai, X. (2021) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2021/9987097 · Cited by 51 · see citing works
Koppen, L. M., Whitaker, A., Rosene, A., & Beckett, R. D. (2017) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587216687695 · Cited by 47 · see citing works
Solnier, J., Zhang, Y., Kuo, Y., Du, M., Roh, K., Gahler, R., Wood, S., & Chang, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112567 · Cited by 47 · see citing works
Self-citationMurakami, T., Bodor, E., & Bodor, N. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2203857 · Cited by 41 · see citing works
Cao, R. Y., Zheng, Y., Zhang, Y., Jiang, L., Li, Q., Sun, W., Gu, W., Cao, W., Zhou, L., Zheng, H., et al. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500762 · Cited by 31 · see citing works
Self-citationXiao, G.-M., Lu, T., Zhu, D., & Liu, M.-Y. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-01026-7 · Cited by 2 · see citing works
Dumitru, C. N., Marcu, T., Dumitru, A. O., Tudor, S. S., Ferțu, I. D., Elisei, A.-M., & Goroftei, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081313 · Cited by 2 · see citing works
“The absolute oral bioavailability of berberine is very low, estimated to be below 1% in rats and below a few percent in humans [48–50], a consequence of its physicochemical properties and of the limited absorption consistently documented in the literature [51–53] of P-glycoprotein-mediated efflux…”
- Authors
- Liu, C.-S., Zheng, Y.-R., Zhang, Y.-F., & Long, X.-Y.
- Affiliations
- Guangdong Pharmaceutical University (CN)
- ORCID
- Liu, Chang-Shun
- Venue
- Fitoterapia
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 109
- Pages
- 274-282
- ISSN
- 0367-326X (ISSN-L)
- OpenAlex
- W2272399875
- Cited by
- 363
- References
- 128
- Citations by year
- 2026: 33 · 2025: 40 · 2024: 33 · 2023: 37 · 2022: 50 · 2021: 46 · 2020: 44 · 2019: 22 · 2018: 25 · 2017: 28 · 2016: 4
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Fitoterapia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81573353)
- Medjaden Academy & Research Foundation for Young Scientists (MJA20160107)
- Topics
- Health Sciences › Medicine › Pharmacology › Berberine and alkaloids research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- berberine, oral bioavailability, pharmacokinetics, drug absorption enhancement, first-pass metabolism, natural products, diabetes mellitus, hyperlipidemia, cancer, metabolic disorders, pharmacological activity
- MeSH terms
- Administration, Oral, Animals, Berberine, Biological Availability, Diabetes Mellitus, Humans, Hyperlipidemias, Neoplasms, Molecular Structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review